Sanginita Chemicals Complete Financial Statements

In FYNone, Sanginita Chemicals (SANGINITA) reported revenue ₹202 Cr, net profit ₹-1 Cr and EPS ₹-0.20, with a net profit margin of 0.4% and ROE of 1.8%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SANGINITA stock overview.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 0.43% 2025 data
EBITDA Margin 2.17% 2025 data
Operating Margin 2.00% 2025 data
Return on Assets 0.98% 2025 data
Return on Equity 1.79% 2025 data

Balance Sheet Ratios

Current Ratio 87.00 2025 data
Debt to Equity 1.82 2025 data
Equity Ratio 54.90% 2025 data
Asset Turnover 2.25 2025 data

SANGINITA Revenue, Net Profit & EBITDA — Year-on-Year Growth

SANGINITA YoY (March 2025 vs Period) — revenue -12.2%, net profit -200.0%, EBITDA -20.0%, expenses -12.0%.

Revenue Growth
-12.2%
Year-over-Year
Net Profit Growth
-200.0%
Year-over-Year
EBITDA Growth
-20.0%
Year-over-Year
Expense Growth
-12.0%
Year-over-Year
Assets Growth
+18.6%
Year-over-Year
Equity Growth
+36.6%
Year-over-Year
Liabilities Growth
+18.6%
Year-over-Year
Operating Cash Flow Growth
+250.0%
Year-over-Year
Investing Cash Flow Growth
-150.0%
Year-over-Year
Financing Cash Flow Growth
+16.7%
Year-over-Year

SANGINITA Income Statement — Revenue, EBITDA & Net Profit

Sanginita Chemicals revenue ₹202 Cr, EBITDA ₹4 Cr, net profit ₹-1 Cr, EPS ₹-0.20 (None) — net profit margin 0.4%. Explore SANGINITA Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016
Revenue 202 230 152 149 198 165 160 188 195 148 144
Expenses 198 225 148 146 195 161 152 178 187 142 140
EBITDA 4 5 4 4 3 4 9 9 8 5 5
Operating Profit Margin % 2.00% 2.00% 3.00% 2.00% 1.00% 2.00% 5.00% 5.00% 4.00% 3.00% 3.00%
Depreciation 2 2 1 1 1 1 1 1 1 0 1
Interest 2 2 3 3 2 3 3 3 2 3 3
Profit Before Tax -1 1 1 1 1 1 5 6 5 2 2
Tax 0 0 0 0 0 0 1 2 2 1 1
Net Profit -1 1 1 0 0 1 3 4 4 1 1
Earnings Per Share (₹) -0.20 0.24 0.45 0.24 0.20 0.44 1.95 2.28 2.00 0.65 1.30

SANGINITA Balance Sheet — Assets, Liabilities & Shareholders' Equity

SANGINITA total assets ₹102 Cr, total equity ₹56 Cr, total liabilities ₹102 Cr (2025) — ROE 1.8%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
ASSETS
Total Assets 102 86 80 79 70 78 72 61 60 44
Current Assets 87 78 70 75 66 74 67 57 57 40
Fixed Assets 15 8 5 4 4 4 4 4 3 4
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0
Other Assets 87 78 75 75 66 74 67 57 57 40
LIABILITIES
Total Liabilities 102 86 80 79 70 78 72 61 60 44
Current Liabilities 1 3 2 4 0 0 0 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 56 41 40 40 39 39 35 31 28 17
Share Capital 26 17 17 17 17 17 17 17 17 9
Reserves & Surplus 30 24 23 23 22 21 18 14 11 8

SANGINITA Cash Flow Statement — Operating, Investing & Financing

Sanginita Chemicals operating cash flow ₹3 Cr, investing ₹-10 Cr, financing ₹7 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 3 -2 14 -3 9 -2 1 3 -7 0 2
Investing Activities -10 -4 -1 -1 0 -1 -1 -1 0 0 0
Financing Activities 7 6 -13 4 -8 2 0 -2 8 0 -2
Net Cash Flow 0 0 0 0 0 0 0 0 0 0 0